Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M180,289Revenue (TTM) $M39,807Net Margin (%)14.3Altman Z-Score--
Enterprise Value $M180,289EPS (TTM) $2.0Operating Margin %22.5Piotroski F-Score--
P/E(ttm)32.2Beneish M-Score--Pre-tax Margin (%)18.8Higher ROA y-yN
Price/Book4.110-y EBITDA Growth Rate %-7.4Quick Ratio--Cash flow > EarningsN
Price/Sales4.65-y EBITDA Growth Rate %-31.5Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow32.1y-y EBITDA Growth Rate %-92.0ROA % (ttm)5.7Higher Current Ratio y-yN
Dividend Yield %2.8PEG--ROE % (ttm)12.9Less Shares Outstanding y-yN
Payout Ratio %94.0Shares Outstanding M2,757ROIC % (ttm)12.0Gross Margin Increase y-yN

Gurus Latest Trades with MRK

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

MRK is held by these investors:



MRK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Karachun Rita ASr. VP Fince-Global Controller 2017-02-14Sell2,954$64.731.02view
RUSSO PATRICIA FDirector 2017-02-08Sell5,000$64.421.51view
WEEKS WENDELL PDirector 2017-02-06Sell5,000$64.511.36view
WENDELL PETER CDirector 2017-02-03Sell15,000$63.692.67view
Holston Michael JEVP, General Counsel 2017-02-03Sell91,959$63.962.24view
Schechter Adam HEVP & Pres-Global Human Health 2017-02-03Sell36,335$63.732.6view
Cech Thomas RDirector 2017-02-03Sell5,000$63.423.11view
FRAZIER KENNETH CChairman, President & CEO 2016-11-10Sell140,000$65.030.55view
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy 2016-11-07Sell85,523$60.028.95view
LAZARUS ROCHELLE BDirector 2016-11-02Sell20,000$59.0610.72view

Press Releases about MRK :

Quarterly/Annual Reports about MRK:

News about MRK:

Articles On GuruFocus.com
Dow Jones Closes at 20,504.41 Feb 15 2017 
Nasdaq Reaches a New High on Wednesday Feb 08 2017 
Merck: Analyzing 2016 Performance and Outlook for 2017 Feb 04 2017 
Is Bristol-Meyers a Buy After 39% Price Decline? Jan 29 2017 
US Market Indexes Lower on Monday Jan 24 2017 
US Market Indexes Lower for the Week Jan 21 2017 
US Market Indexes Higher After Trump Press Conference Jan 11 2017 
US Market Indexes Trade Flat Jan 10 2017 
Gilead Sciences Must Answer to Investors After a Disappointing 2016 Jan 05 2017 
US Market Indexes Start the New Year Higher Jan 03 2017 

More From Other Websites
Merck, Bristol-Myers, Incyte Race For A Cure In $25 Billion I-O Market Feb 17 2017
Clovis, Tesaro Soar on Astrazeneca Phase Three News Feb 17 2017
Prolia Expected to Be a Significant Growth Driver for Amgen in 2017 Feb 17 2017
After-hours buzz: ANET, TRUE, MRK & more Feb 16 2017
Merck HIV Drug Doravirine Reports Positive Results Feb 16 2017
Health Care ETF Has Been Ailing Feb 16 2017
What's Driving Lilly's (LLY) Shares after 2016 Decline? Feb 16 2017
Alzheimer's Market Suffers Yet Another Blow with Merck Drug Setback Feb 16 2017
Merck’s Fight Against Infectious Disease Goes Digital with Launch of ILÚM Health Solutions Feb 16 2017
DexCom Is a Great Healthcare Stock to Buy Now Feb 15 2017
Fossil and AIG slump, Procter & Gamble and Fortress jump Feb 15 2017
Fossil and AIG slump, Procter & Gamble and Fortress jump Feb 15 2017
Incyte's (INCY) Beats on Q4 Earnings, Provides 2017 Outlook Feb 15 2017
Merck Delivers Even More Disappointing News in Alzheimer’s Study Feb 15 2017
[$$] Merck's drug failure deals further blow to Alzheimer's theory Feb 15 2017
Merck Halts Late-Stage Alzheimer’s Drug Trial Feb 15 2017
Eli Lilly Is Great Stock to Buy Now Feb 15 2017
Dow Jones Closes at 20,504.41 Feb 15 2017
Stocks to Watch: February 15, 2017 Feb 15 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)